Hospital
Steward Sharon Regional Health System, INC.
Steward Sharon Regional Health System, INC. was paid $5.84M by Medicaid between Jan 2018 and Dec 2024, across 213 billing codes. Its largest line is 99285, emergency room visit (most serious) — 19% of everything it billed.
33Billing provider infoSTEWARD SHARON REGIONAL HEALTH SYSTEM, INC.
SHARON, PA 16146
SHARON, PA 16146
33aNPI1790219616assigned 04/18/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.84M
24GClaims204,195
24DCodes billed213
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#51 of 154
Median peer was paid$2.82M
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOYLE, JOHN controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 932 | $27K | |
| 2019 | 3,238 | $36K | |
| 2020 | 20,441 | $387K | |
| 2021 | 93,068 | $2.28M | |
| 2022 | 30,942 | $1.13M | |
| 2023 | 36,735 | $1.21M | |
| 2024incomplete | 18,839 | $764K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 8,985 | 8,324 | $1.14M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 14,925 | 14,303 | $1.03M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 10,455 | 9,970 | $972K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 12% | 8,412 | 5,318 | $682K |
| G0378 | Hospital observation service, per hour | 2.7% | 458 | 264 | $157K |
| 80053 | Comprehensive metabolic panel | 2.0% | 14,544 | 13,245 | $119K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 5,545 | 5,123 | $107K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 1,381 | 1,271 | $106K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 2,808 | 2,580 | $104K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 515 | 498 | $85K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 1,138 | 1,083 | $79K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 3,487 | 826 | $68K |
201 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 742 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 15,247 | $62K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,317 | $58K |
| 80050 | General health panel | <1% | 1,171 | $51K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,000 | $47K |
| 84484 | <1% | 6,652 | $44K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,856 | $36K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 512 | $35K |
| 83880 | <1% | 1,453 | $33K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,088 | $27K |
| 80061 | Lipid panel | <1% | 2,224 | $25K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 685 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,308 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 967 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,695 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 955 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,281 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,166 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,436 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 525 | $18K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 206 | $16K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 563 | $16K |
| 81001 | <1% | 6,965 | $15K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 187 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,011 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,687 | $12K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 44 | $11K |
| 93971 | <1% | 183 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,591 | $10K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 80 | $10K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 59 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,442 | $10K |
| 83735 | <1% | 2,175 | $10K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 237 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 979 | $9K |
| 87081 | <1% | 1,705 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 283 | $9K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 234 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 219 | $8K |
| 83690 | <1% | 2,266 | $8K | |
| 83605 | <1% | 1,530 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 372 | $8K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 127 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 141 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 427 | $8K |
| 93017 | <1% | 258 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 346 | $7K |
| 84703 | <1% | 880 | $7K | |
| 94729 | <1% | 273 | $7K | |
| 85610 | <1% | 2,294 | $7K | |
| 88342 | <1% | 143 | $6K | |
| 94726 | <1% | 259 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 159 | $6K |
| 82607 | <1% | 525 | $5K | |
| 84439 | <1% | 754 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 206 | $5K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 850 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 172 | $5K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 106 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 62 | $5K |
| 81025 | <1% | 1,622 | $5K | |
| 87481 | <1% | 136 | $5K | |
| 73610 | <1% | 302 | $5K | |
| 97113 | <1% | 247 | $4K | |
| 85379 | <1% | 553 | $4K | |
| 86803 | <1% | 227 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 141 | $4K |
| 97161 | <1% | 246 | $4K | |
| 84702 | <1% | 248 | $4K | |
| 87040 | <1% | 396 | $4K | |
| 85027 | <1% | 664 | $4K | |
| 82728 | <1% | 361 | $4K | |
| 93975 | <1% | 30 | $4K | |
| 73630 | <1% | 316 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 60 | $3K |
| 86780 | <1% | 198 | $3K | |
| 96376 | <1% | 258 | $3K | |
| 83540 | <1% | 446 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,271 | $3K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 192 | $3K |
| 97010 | <1% | 643 | $3K | |
| 76801 | <1% | 74 | $3K | |
| 82570 | <1% | 434 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 682 | $3K |
| 84466 | <1% | 191 | $2K | |
| 80074 | <1% | 48 | $2K | |
| 82043 | <1% | 343 | $2K | |
| 86038 | <1% | 173 | $2K | |
| 73130 | <1% | 237 | $2K | |
| 73030 | <1% | 197 | $2K | |
| 87186 | <1% | 308 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 263 | $2K |
| 84460 | <1% | 331 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 352 | $2K |
| 85730 | <1% | 371 | $2K | |
| 84450 | <1% | 329 | $2K | |
| 86850 | <1% | 314 | $2K | |
| 93970 | <1% | 27 | $2K | |
| 85007 | <1% | 534 | $2K | |
| 76775 | <1% | 44 | $2K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 379 | $2K |
| 84481 | <1% | 77 | $2K | |
| 84145 | <1% | 122 | $2K | |
| 80076 | <1% | 196 | $2K | |
| 82947 | <1% | 551 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,672 | $2K |
| 85652 | <1% | 527 | $1K | |
| 94010 | <1% | 139 | $1K | |
| 82565 | <1% | 260 | $1K | |
| 87077 | <1% | 238 | $1K | |
| 73564 | <1% | 85 | $1K | |
| 81003 | <1% | 553 | $1K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $1K |
| 83970 | <1% | 41 | $1K | |
| 82150 | <1% | 250 | $1K | |
| 76536 | <1% | 29 | $1K | |
| 86900 | <1% | 362 | $1K | |
| 73110 | <1% | 119 | $1K | |
| 86901 | <1% | 362 | $1K | |
| 72131 | <1% | 12 | $1K | |
| 84100 | <1% | 187 | $1K | |
| 73562 | <1% | 69 | $1K | |
| 86140 | <1% | 341 | $967.27 | |
| 82784 | <1% | 38 | $908.73 | |
| 97162 | <1% | 41 | $904.69 | |
| 87340 | <1% | 60 | $842.82 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 747 | $810.03 |
| 86762 | <1% | 39 | $800.11 | |
| 90715 | <1% | 48 | $772.46 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 221 | $762.63 |
| 72100 | <1% | 41 | $753.75 | |
| 88142 | <1% | 56 | $734.40 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 27 | $712.44 |
| 82746 | <1% | 81 | $698.69 | |
| 93226 | <1% | 25 | $682.37 | |
| 87070 | <1% | 148 | $657.08 | |
| 83550 | <1% | 148 | $647.97 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $630.48 |
| 72110 | <1% | 37 | $614.88 | |
| 12001 | <1% | 28 | $612.50 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $562.65 |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $525.12 |
| 76642 | <1% | 17 | $506.28 | |
| 76770 | <1% | 12 | $493.20 | |
| 73502 | <1% | 26 | $470.71 | |
| 87205 | <1% | 157 | $458.34 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 299 | $448.80 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,112 | $435.98 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 217 | $435.80 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,334 | $423.83 |
| 97750 | <1% | 52 | $412.10 | |
| 86430 | <1% | 58 | $401.67 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 19 | $370.00 |
| 86618 | <1% | 15 | $336.58 | |
| 10060 | <1% | 13 | $313.85 | |
| 82962 | <1% | 313 | $309.40 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 13 | $309.00 |
| 87147 | <1% | 84 | $306.60 | |
| 93225 | <1% | 25 | $283.93 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 45 | $283.50 |
| 82550 | <1% | 47 | $280.44 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,196 | $268.71 |
| 73080 | <1% | 28 | $261.94 | |
| 84436 | <1% | 28 | $261.58 | |
| 83516 | <1% | 17 | $243.17 | |
| 72050 | <1% | 12 | $229.55 | |
| 97597 | <1% | 47 | $208.14 | |
| 84550 | <1% | 46 | $205.46 | |
| 97035 | <1% | 38 | $204.06 | |
| 84520 | <1% | 45 | $167.33 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 14 | $167.15 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,555 | $164.97 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 758 | $140.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 269 | $138.41 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 357 | $125.39 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 36 | $124.20 |
| 87075 | <1% | 16 | $121.00 | |
| 88304 | <1% | 40 | $117.24 | |
| 87088 | <1% | 16 | $112.80 | |
| 82077 | <1% | 131 | $110.97 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 68 | $105.67 |
| 83721 | <1% | 24 | $93.30 | |
| 82248 | <1% | 14 | $92.49 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 68 | $63.81 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 942 | $62.77 |
| 80179 | <1% | 48 | $53.36 | |
| 80143 | <1% | 49 | $53.36 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 174 | $51.02 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 212 | $47.35 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 56 | $44.82 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 63 | $37.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 335 | $30.44 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 193 | $28.96 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $22.00 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 93 | $21.53 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 800 | $13.37 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 77 | $7.23 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 255 | $1.52 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 12 | $0.00 |
| 00731 | 0% | 14 | $0.00 | |
| 92552 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOYLE, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Steward ST. Annes Hospital Corporation | Fall River, MA | $82.71M |
| Steward Trumbull Memorial Hospital, INC. | Warren, OH | $16.49M |
| Steward Sharon Regional Health System, INC. | Sharon, PA | $6.76M |
| Steward Rockledge Hospital, INC. | Rockledge, FL | $6.16M |
| Southwest General Hospital LP | San Antonio, TX | $5.84M |
| SHC Youngstown Ohio Laboratory Services Company LLC | Poland, OH | $3.41M |
| Steward Melbourne Hospital, INC. | Melbourne, FL | $3.35M |
| Steward Hillside Rehabilitation Hospital, INC. | Warren, OH | $2.74M |
| Steward Sebastian River Medical Center, INC. | Sebastian, FL | $2.16M |
| Steward Northside Medical Center, INC. | Youngstown, OH | $1.58M |
| Steward Rockledge Hospital, INC. | Rockledge, FL | $974K |
| Newberry County EMS | Newberry, SC | $758K |
| Steward Sharon Regional Health System, INC. | Mercer, PA | $181K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.